Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Quintiliani

Showing results (161-170 of 276) with videos related to

Pageof 28
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 15, 1997
Cost comparison of single daily i.v. doses of ceftriaxone versus continuous infusion of cefotaximeC M Hitt, C H Nightingale, R Quintiliani, et al.
Current Therapeutic Research, Clinical and Experimental|April 1, 1975
Further observations on the antimicrobial effects of local anesthetic agentsM P Weinstein, E Maderazo, R Tilton, et al.
Connecticut Medicine|August 1, 1993
Oral ciprofloxacin, ofloxacin, and lomefloxacin as alternatives to intravenous antimicrobial therapyP Belliveau, C H Nightingale, R Quintiliani, et al.
Connecticut Medicine|May 17, 2000
Quinupristin/dalfopristin: a treatment option for vancomycin-resistant EnterococciM K Kim, D P Nicolau, C H Nightingale, et al.
Pharmacoeconomics|June 6, 1996
Pharmacoeconomics of Pneumocystis carinii pneumonia in HIV-infected and HIV-noninfected patientsD P Nicolau, J W Ross, R Quintiliani, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1996
Comparative serum bactericidal activities of ceftizoxime and cefotaxime against intermediately penicillin-resistant Streptococcus pneumoniaeK B Patel, D P Nicolau, C H Nightingale, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1988
Effect of protein binding on drug penetration into blister fluidW C Shyu, R Quintiliani, C H Nightingale, et al.
DICP : the Annals of Pharmacotherapy|March 1, 1991
Cost considerations of conversion from aminoglycoside-containing combination regimens to ceftriaxoneL L Briceland, W R Outman, C H Nightingale, et al.
The Journal of Infectious Diseases|November 1, 1981
Stability of cephalosporins in commercial seraW C Shyu, C H Nightingale, R Quintiliani, et al.
Archives of Internal Medicine|May 1, 1986
Therapy of Mycobacterium marinum infections. Use of tetracyclines vs rifampinS T Donta, P W Smith, R E Levitz, et al.
Pageof 28

Showing results (161-170 of 276) with videos related to

Sort By:
Pageof 28
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 15, 1997
Cost comparison of single daily i.v. doses of ceftriaxone versus continuous infusion of cefotaximeC M Hitt, C H Nightingale, R Quintiliani, et al.
Current Therapeutic Research, Clinical and Experimental|April 1, 1975
Further observations on the antimicrobial effects of local anesthetic agentsM P Weinstein, E Maderazo, R Tilton, et al.
Connecticut Medicine|August 1, 1993
Oral ciprofloxacin, ofloxacin, and lomefloxacin as alternatives to intravenous antimicrobial therapyP Belliveau, C H Nightingale, R Quintiliani, et al.
Connecticut Medicine|May 17, 2000
Quinupristin/dalfopristin: a treatment option for vancomycin-resistant EnterococciM K Kim, D P Nicolau, C H Nightingale, et al.
Pharmacoeconomics|June 6, 1996
Pharmacoeconomics of Pneumocystis carinii pneumonia in HIV-infected and HIV-noninfected patientsD P Nicolau, J W Ross, R Quintiliani, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1996
Comparative serum bactericidal activities of ceftizoxime and cefotaxime against intermediately penicillin-resistant Streptococcus pneumoniaeK B Patel, D P Nicolau, C H Nightingale, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1988
Effect of protein binding on drug penetration into blister fluidW C Shyu, R Quintiliani, C H Nightingale, et al.
DICP : the Annals of Pharmacotherapy|March 1, 1991
Cost considerations of conversion from aminoglycoside-containing combination regimens to ceftriaxoneL L Briceland, W R Outman, C H Nightingale, et al.
The Journal of Infectious Diseases|November 1, 1981
Stability of cephalosporins in commercial seraW C Shyu, C H Nightingale, R Quintiliani, et al.
Archives of Internal Medicine|May 1, 1986
Therapy of Mycobacterium marinum infections. Use of tetracyclines vs rifampinS T Donta, P W Smith, R E Levitz, et al.
Pageof 28